LIPC and coronary artery disorder: A reduction in CAD risk was found with respect to the CUBN rs2291521GA/HNF1A rs55783344CC/LIPC rs17269397AG genotype combination (AOR = 0.329; 95% CI 0.141–0.764; P = 0.010) (see Supplementary Table S3).